Bradley J. Schnierow

M.D. | Neurology


  9834 Genesee Avenue, Suite 112, La Jolla
     California, 92037
  858-623-3266    858-630-2426 Maps & Directions
Bradley J. Schnierow is a La Jolla, California based neurologist who is specialized in Neurology. His current practice location is 9834 Genesee Avenue, Suite 112, La Jolla. Patients can reach him at 858-623-3266 or can fax him at 858-630-2426. Bradley J. Schnierow is M.D. in Neurology and his NPI number (Unique professional ID assigned by NPPES) is 1801832522.
Bradley J. Schnierow specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
Bradley J. Schnierow speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for appointment.
Name: Bradley J. Schnierow
Specialization: Neurology
Gender:Male
Credentials: M.D.
Practice Address:9834 Genesee Avenue, Suite 112, La Jolla,
California, 92037
Phone:858-623-3266
Fax:858-630-2426
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number: 1801832522
NPI Enumeration Date: 21 Jun, 2006
NPI Last Update On: 27 Sep, 2010

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: Bradley J. Schnierow
13537 Mango Drive,
Del Mar, California
Zip: 92014-3538
Phone Number: 858-623-3266
Fax Number: 858-630-2426
Patients can reach Bradley J. Schnierow at 9834 Genesee Avenue, Suite 112, La Jolla, California or can call to book an appointment on 858-623-3266.
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 May, 2024.